Company · CIK 0001100397
Ayala Pharmaceuticals, Inc.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- SCHEDULE 13GOS Therapies Inc0001641172-25-005014 · 8.4 KBSEC(opens sec.gov)
- 10-K/AAyala Pharmaceuticals, Inc.0001493152-24-016714 · 578.4 KBSEC(opens sec.gov)
- 8-K/AAyala Pharmaceuticals, Inc.0000929638-24-001532 · 309.4 KBSEC(opens sec.gov)
- 10-KAnnual report0001493152-24-014822 · 9.0 MBSEC(opens sec.gov)
- 8-KCurrent report0000929638-24-001326 · 145.2 KBSEC(opens sec.gov)
- 8-KCurrent report0000929638-24-001313 · 172.5 KBSEC(opens sec.gov)
- 8-KCurrent report0000929638-24-000901 · 508.0 KBSEC(opens sec.gov)
- 8-KCurrent report0000929638-24-000753 · 163.0 KBSEC(opens sec.gov)
- SC 13G/AAyala Pharmaceuticals, Inc.0001104659-24-023786 · 73.2 KBSEC(opens sec.gov)
- SC 13D/AAyala Pharmaceuticals, Inc.0001178913-24-000459 · 220.3 KBSEC(opens sec.gov)
Insiders
- ADAGE CAPITAL PARTNERS GP, L.L.C.10% Owner
- Adage Capital Partners, L.P.10% Owner
- aMoon Growth Fund Limited Partnership10% Owner
- APPEL RONIDirector
- Atchinson Robert10% Owner
- Berlin Kenneth APresident and CEO
- BERMAN RICHARD JDirector
- Bisker-Leib VeredDirector
- Bonstein SaraChief Financial Officer
- Cabilly YuvalDirector
Tickers
No tickers on record.
Addresses
business
9 DEER PARK DRIVE SUITE K-1
MONMOUTH JUNCTION, NJ, 08852
mailing
9 DEER PARK DRIVE SUITE K-1
MONMOUTH JUNCTION, NJ, 08852
Former names
- Advaxis, Inc.2023-01-13
- GREAT EXPECTATIONS & ASSOCIATES INC2005-01-05
Same industry